Press Releases

Former FDA Senior Official Michael Chappell Joins Greenleaf Health LLC

Greenleaf Health LLC today announced that Michael Chappell, former Acting Associate Commissioner for Regulatory Affairs at the Food and Drug Administration (“FDA”), has joined the firm as Senior Advisor. Greenleaf Health is a full service...

Rhenovia Pharma opens first US office

Rhenovia Pharma SAS, a biotechnology company specializing in biosimulation applied to the discovery of new medications to treat brain diseases such as Alzheimer’s, today announces its first international subsidiary, Rhenovia Inc, incorporated in Delaware. Rhenovia’s new...

NovaDel Announces Termination of License Agreements for Ondansetron Oral Spray Product

NovaDel Pharma Inc., a specialty pharmaceutical company that develops oral spray formulations of marketed pharmaceutical products, today announced the termination of certain license agreements with Talon Therapeutics, Inc. and Par Pharmaceutical Companies, Inc., relating to the development and commercialization...

Polyplus-transfection launches the next generation PEI transfection reagent for bioproduction

Polyplus-transfection SA, specializing in the development of innovative solutions for transfection, today announces the launch of PEIpro, the next generation linear PEI (polyethylenimine) transfection reagent for large scale production of proteins, antibodies and viral vectors. ...

Incisive Surgical Announces Breakthrough Peer Review Clinical Study

Incisive Surgical, Inc. today announced a peer-reviewed publication of a profound clinical study.   The study, titled "Skin Closure With Subcuticular Absorbable Staples After Cesarean Section Is Associated With Decreased Analgesic Use," was published online by...

Klemens Schuette Appointed Managing Director at Ecron Acunova Germany (EAG)

D A Prasanna, Founder and Chairman of Ecron Acunova group (EA), is pleased to announce the appointment of Klemens Schuette as Managing Director Germany. Mr Schuette joins the Managing Director of EA Germany & CEO Europe, Dr Klaus...

RBCC Enters New World of Opportunity

Rainbow Coral Corp. positioned itself at the cutting edge of biotechnology innovation today by joining forces with BioHouston, Inc., one of the nation’s preeminent drivers of life sciences research and commercialization. Home to the world’s largest...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read